[EN] PROCESS FOR PREPARATION OF ACITRETIN<br/>[FR] PROCÉDÉ DE PRÉPARATION D'ACITRÉTINE
申请人:EMCURE PHARMACEUTICALS LTD
公开号:WO2016042573A1
公开(公告)日:2016-03-24
The present invention provides a process for preparation of (2E,4E,6E,8E)-9-(4-methoxy-2,3,6- trimethyl)phenyl-3,7-dimethyl-nona-2,4,6,8}tetraenoate, an acitretin intermediate of formula (VI) with trans isomer ≥97%, comprising of reacting 3-formyl-crotonic acid butyl ester of formula (V), substantially free of impurities, with 5-(4-methoxy-2,3,6-trimethylphenyl)-3- methyl-penta-2,4-diene-l-triphenyl phosphonium bromide of formula (IV) and isolating resultant compound of formula (VI), treating the filtrate with iodine for isomerization of the undesired cis intermediate and finally obtaining acitretin (I), with desired trans isomer ≥97%.
本发明提供了一种制备(2E,4E,6E,8E)-9-(4-甲氧基-2,3,6- 三甲基)苯基-3,7-二甲基-壬二烯酸酯,即式(VI)的乙酸类似物的过程,其反应物为式(V)的3-甲酰基-巴比妥酸酯,基本无杂质,与式(IV)的5-(4-甲氧基-2,3,6-三甲基苯基)-3-甲基-戊二烯-1-三苯基磷溴化铵反应,并分离产物(VI)的化合物,用碘处理滤液以异构化不需要的顺式中间体,最终获得乙酸类似物(I),其所需的顺式异构体≥97%。